Interleukin-10 antibodies

Details for Australian Patent Application No. 2011200606 (hide)

Owner Schering Corporation

Inventors Presta, Leonard G.

Agent Griffith Hack

Pub. Number AU-B-2011200606

Parent 2004290044

Filing date 14 February 2011

Wipo publication date 3 March 2011

Acceptance publication date 10 May 2012

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

3 March 2011 Application Open to Public Inspection

  Published as AU-B-2011200606

3 March 2011 Complete Application Filed

10 May 2012 Application Accepted

  Published as AU-B-2011200606

6 September 2012 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011200607-Hydrogen Fuelled Hybrid Powertrain and Vehicle

2011200605-Methods and systems for managing risk managment information